SAN FRANCISCO, Sept. 8, 2011 /CNW/ - Cloud Dx, a division of Biosign
Technologies Inc. (TSXV: BIO), a medical device company focused on
non-invasive, cloud-based health monitoring, is proud to be the sponsor
of the "In Conversation with 3 CEO's" panel at the Health 2.0
"In Conversation with 3 CEO's" panel features Anne Wojcicki of 23andme,
Sona Mehring of Caring Bridge, and West Shell of Healthline. Cloud Dx,
CEO, Dr. Scott Jenkins will introduce the panel and topic to the
attendees (expected to exceed 1,000) and speak briefly about the Cloud
Dx solution to complete the circle of care utilizing its uFit®
technology and remote cloud monitoring systems.
The Health 2.0 Annual Fall Conference is being held in San Francisco at
the Hilton, Union Square September 25-27, 2011. Health 2.0 is known for
showcasing innovative healthcare technology and bringing together the
industry's top thought leaders.
About Biosign Technologies Inc
Biosign Technologies Inc. (TSXV: BIO) provides biomedical systems. Cloud
Dx applications include intelligent systems for noninvasive monitoring
of common health risks associated with blood pressure, glucose, and
medication. Biosign technology combines measurement, analysis, and
tools for disease and patient management to support global health
monitoring. The uFit® medical device delivers quality data collection
and analytics for clinical diagnostics, self-care, wellness, disease
state evaluation and management, and remote patient monitoring. For
more information visit www.biosign.com.
SOURCE Biosign Technologies Inc.
For further information:
Cloud Dx Contact: